User profiles for Sophie A. Kitchen
 | Sophie A. KitchenEpidemiologist Verified email at analysisgroup.com Cited by 641 |
[HTML][HTML] Risk factors for misuse of prescribed opioids: a systematic review and meta-analysis
A Cragg, JP Hau, SA Woo, SA Kitchen, C Liu… - Annals of emergency …, 2019 - Elsevier
Study objective Increasing opioid prescribing has been linked to an epidemic of opioid
misuse. Our objective is to synthesize the available evidence about patient-, prescriber-, …
misuse. Our objective is to synthesize the available evidence about patient-, prescriber-, …
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study
R Grewal, SA Kitchen, L Nguyen, SA Buchan… - Bmj, 2022 - bmj.com
Objectives To estimate the marginal effectiveness of a fourth versus third dose and the
vaccine effectiveness of mRNA covid-19 vaccines BNT162b2 and mRNA-1273 against any …
vaccine effectiveness of mRNA covid-19 vaccines BNT162b2 and mRNA-1273 against any …
Measuring the burden of opioid-related mortality in Ontario, Canada, during the COVID-19 pandemic
T Gomes, SA Kitchen, R Murray - JAMA Network Open, 2021 - jamanetwork.com
The COVID-19 pandemic struck in the midst of an epidemic of opioid overdoses that has
resulted in nearly 20 000 deaths in Canada since 2016. 1 Pandemic-mandated measures, …
resulted in nearly 20 000 deaths in Canada since 2016. 1 Pandemic-mandated measures, …
Association between increased dispensing of opioid agonist therapy take-home doses and opioid overdose and treatment interruption and discontinuation
Importance During the COVID-19 pandemic, modified guidance for opioid agonist therapy (OAT)
allowed prescribers to increase the number of take-home doses to promote treatment …
allowed prescribers to increase the number of take-home doses to promote treatment …
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis
SA Kitchen, TJ Campbell, S Men, N Bozinoff… - International Journal of …, 2022 - Elsevier
Background In March 2020, the Ontario government declared a state of emergency due to
the growing risk of COVID-19. In response, new guidance for the management of opioid …
the growing risk of COVID-19. In response, new guidance for the management of opioid …
Vaccine effectiveness of BNT162b2 against delta and omicron variants in adolescents
SA Buchan, L Nguyen, SE Wilson, SA Kitchen… - …, 2022 - publications.aap.org
Methods We conducted a test-negative design study among individuals aged 12 to 17 years
and SARS-CoV-2 tested (by real-time reverse transcription polymerase chain reaction) …
and SARS-CoV-2 tested (by real-time reverse transcription polymerase chain reaction) …
The effects of COVID‐19 on the dispensing rates of antidepressants and benzodiazepines in Canada
…, M Tadrous, SN Vigod, SA Kitchen… - Depression and …, 2022 - Wiley Online Library
Background Population studies have shown that rates of depressive and anxious symptoms
have increased as a result of COVID‐19. We analyzed trends in the dispensing rates of …
have increased as a result of COVID‐19. We analyzed trends in the dispensing rates of …
[HTML][HTML] Trends in hospitalizations for serious infections among people with opioid use disorder in Ontario, Canada
Objectives Opioid use among people who inject drugs can lead to serious complications,
including infections. We sought to study trends in rates of these complications among people …
including infections. We sought to study trends in rates of these complications among people …
[HTML][HTML] Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: A population-based time series analysis
R Garg, SA Kitchen, S Men, TJ Campbell… - Drug and Alcohol …, 2022 - Elsevier
Background We assessed the impact of COVID-19, which includes the declaration of a state
of emergency and subsequent release of pandemic-specific OAT guidance (March 17, 2020 …
of emergency and subsequent release of pandemic-specific OAT guidance (March 17, 2020 …
Effectiveness of a fourth dose of COVID-19 vaccine among long-term care residents in Ontario, Canada: test-negative design study
R Grewal, SA Kitchen, L Nguyen, SA Buchan… - medRxiv, 2022 - medrxiv.org
Background As of December 30, 2021, Ontario long-term care (LTC) residents who received
a third dose of COVID-19 vaccine ≥84 days previously were offered a fourth dose to …
a third dose of COVID-19 vaccine ≥84 days previously were offered a fourth dose to …